Literature DB >> 3210852

[En-bloc resection of the esophagus in esophageal cancer].

J R Siewert1, A H Hölscher, J Roder, H Bartels.   

Abstract

En-bloc esophagectomy not only comprises the elimination of the esophagus but also the mediastinal lymphadenectomy and the resection of the azygos vein and thoracic duct. Additionally the suprapancreatic abdominal lymphadenectomy is included and in tumors located orally of the tracheal bifurcation also the cervical lymphadenectomy. The surgical technique can be estimated as fully developed and standardized. Possible complications are postoperative hemorrhage (3.3%), chylothorax (1.6%) and tracheal lesions (4.9%). The mortality rate ranges under 10% in experienced centers, in our own patients around 6.6%. With en-bloc esophagectomy an exact staging of esophageal cancer becomes possible. In a high percentage complete tumor elimination (R0-resection) can be achieved and it seems that herewith prognosis in early tumor stages (T1/2N0/1) can be improved.

Entities:  

Mesh:

Year:  1988        PMID: 3210852     DOI: 10.1007/bf01272555

Source DB:  PubMed          Journal:  Langenbecks Arch Chir        ISSN: 0023-8236


  13 in total

1.  THE SURGICAL TREATMENT OF CARCINOMA OF THE ESOPHAGUS AND CARDIA.

Authors:  A LOGAN
Journal:  J Thorac Cardiovasc Surg       Date:  1963-08       Impact factor: 5.209

2.  Assessment of resectability of esophageal cancer by computed tomography and magnetic resonance imaging.

Authors:  L Lehr; N Rupp; J R Siewert
Journal:  Surgery       Date:  1988-03       Impact factor: 3.982

Review 3.  [Achievements of tumor surgery in tumors of the esophagus].

Authors:  J R Siewert
Journal:  Langenbecks Arch Chir       Date:  1988

4.  [Lymphadenectomy in stomach cancer].

Authors:  J R Siewert; J Lange; K Böttcher; K Becker; A Stier
Journal:  Langenbecks Arch Chir       Date:  1986

5.  Quality of life and patterns of recurrence following transhiatal esophagectomy for cancer: results of a prospective follow-up in 50 patients.

Authors:  P A Barbier; P J Luder; G Schüpfer; C D Becker; H E Wagner
Journal:  World J Surg       Date:  1988-04       Impact factor: 3.352

6.  Long-term evaluation of patients treated by radical operation for carcinoma of the thoracic esophagus.

Authors:  T Nishihira; T Watanabe; N Ohmori; M Kitamura; T Toyoda; K Hirayama; S Kawachi; J Kuramoto; T Kanoh; T Akaishi
Journal:  World J Surg       Date:  1984-10       Impact factor: 3.352

7.  En bloc resection for neoplasms of the esophagus and cardia.

Authors:  D B Skinner
Journal:  J Thorac Cardiovasc Surg       Date:  1983-01       Impact factor: 5.209

8.  Principles of surgical treatment for carcinoma of the esophagus: analysis of lymph node involvement.

Authors:  H Akiyama; M Tsurumaru; T Kawamura; Y Ono
Journal:  Ann Surg       Date:  1981-10       Impact factor: 12.969

9.  A proposal for a new TNM classification of esophageal carcinoma. Japanese Committee for Registration of Esophageal Carcinoma.

Authors: 
Journal:  Jpn J Clin Oncol       Date:  1985-12       Impact factor: 3.019

10.  Diagnostic, therapeutic, and prognostic features of cancers of the esophagus: results of the international prospective study conducted by the OESO group (790 patients).

Authors:  R Giuli; H Sancho-Garnier
Journal:  Surgery       Date:  1986-05       Impact factor: 3.982

View more
  9 in total

1.  [En bloc esophagectomy--when should the digestive tract be reconstructed?].

Authors:  J R Siewert; H Bartels; J Lange; J D Roder; A H Hölscher
Journal:  Langenbecks Arch Chir       Date:  1990

Review 2.  pTNM and residual tumor classifications: problems of assessment and prognostic significance.

Authors:  P Hermanek
Journal:  World J Surg       Date:  1995 Mar-Apr       Impact factor: 3.352

3.  Extensive lymphadenectomy for thoracic esophageal carcinoma: a two-stage operation for high-risk patients.

Authors:  T Saito; K Shimoda; Y Shigemitsu; T Kinoshita; M Miyahara; M Kobayashi
Journal:  Surg Today       Date:  1994       Impact factor: 2.549

4.  Neoadjuvant therapy of esophageal squamous cell carcinoma: response evaluation by positron emission tomography.

Authors:  B L Brücher; W Weber; M Bauer; U Fink; N Avril; H J Stein; M Werner; F Zimmerman; J R Siewert; M Schwaiger
Journal:  Ann Surg       Date:  2001-03       Impact factor: 12.969

5.  Endodissection of the thoracic esophagus. Technique and clinical results in transhiatal esophagectomy.

Authors:  R Bumm; A H Hölscher; H Feussner; M Tachibana; H Bartels; J R Siewert
Journal:  Ann Surg       Date:  1993-07       Impact factor: 12.969

6.  Using Q-RT-PCR to measure cyclin D1, TS, TP, DPD, and Her-2/neu as predictors for response, survival, and recurrence in patients with esophageal squamous cell carcinoma following radiochemotherapy.

Authors:  Björn L D M Brücher; Gisela Keller; Martin Werner; Ulrike Müller; Silke Lassmann; Antonello Domenico Cabras; Falko Fend; Raymonde Busch; Hubert Stein; Hans-Dieter Allescher; Michael Molls; J Rüdiger Siewert; Heinz Höfler; Katja Specht
Journal:  Int J Colorectal Dis       Date:  2008-08-13       Impact factor: 2.571

7.  Hemodynamic changes after resection of thoracic duct for en bloc resection of esophageal cancer.

Authors:  M Imamura; Y Shimada; T Kanda; T Miyahara; M Hashimoto; T Tobe; T Arai; Y Hatano
Journal:  Surg Today       Date:  1992       Impact factor: 2.549

8.  Neoadjuvant continuous infusion of weekly 5-fluorouracil and escalating doses of oxaliplatin plus concurrent radiation in locally advanced oesophageal squamous cell carcinoma: results of a phase I/II trial.

Authors:  S Lorenzen; B Brücher; F Zimmermann; H Geinitz; J Riera; T Schuster; N Roethling; H Höfler; K Ott; C Peschel; J R Siewert; M Molls; F Lordick
Journal:  Br J Cancer       Date:  2008-09-16       Impact factor: 7.640

9.  MicroRNA expression profiling for the prediction of resistance to neoadjuvant radiochemotherapy in squamous cell carcinoma of the esophagus.

Authors:  Julia Slotta-Huspenina; Enken Drecoll; Marcus Feith; Daniel Habermehl; Stephanie Combs; Wilko Weichert; Marcus Bettstetter; Karen Becker; Rupert Langer
Journal:  J Transl Med       Date:  2018-04-25       Impact factor: 5.531

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.